5042 Journal of Medicinal Chemistry, 2010, Vol. 53, No. 13
Hoshino et al.
(20) Fremont, L. Minireview;Biological Effects of Resveratrol. Life
Sci. 2000, 66, 663–673.
(42) Koga, T.; Meydani, M. Effect of Plasma Metabolites of (þ)-
Catechin and Quercetin on Monocyte Adhesion to Human Aortic
Endothelial Cells. Am. J. Clin. Nutr. 2001, 73, 941–948.
(43) Zhang, Z.; Yu, B.; Schmidt, R. R. Synthesis of Mono- and Di-O-β-
D-glucopyranoside Conjugaes of (E)-Resveratrol. Synthesis 2006,
1301–1306.
ꢀ
ꢀ
(21) Carbo, N.; Costelli, P.; Baccino, F. M.; Lopez-Soriano, F. J.;
Argiles, J. M. Resveratrol, a Natural Product Present in Wine,
ꢀ
Decreases Tumour Growth in a Rat Tumour Model. Biochem.
Biophys. Res. Commun. 1999, 254, 739–743.
(22) Roy, P.; Kalra, N.; Prasad, S.; George, J.; Shukla, Y. Chemopre-
ventive Potential of Resveratrol in Mouse Skin Tumors through
Regulation of Mitochondrial and PI3K/AKT Signaling Pathways.
Pharm. Res. 2009, 26, 211–217.
(44) Orsini, F.; Pelizzoni, F.; Verotta, L.; Aburjai, T.; Rogers, C. B.
Isolation, Synthesis, and Antiplatelet Aggregation Activity of
Resveratrol 3-O-β-D-Glucopyranoside and Related Compounds.
J. Nat. Prod. 1997, 60, 1082–1087.
(23) Aziz, M. H.; Kumar, R.; Ahmad, N. Cancer Chemoprevention by
Resveratrol: In Vitro and in Vivo Studies and the Underlying
Mechanisms (Review). Int. J. Oncol. 2003, 23, 17–28.
(24) Chen, Y.; Tseng, S. H.; Lai, H. S.; Chen, W. J. Resveratrol-Induced
Cellular Apoptosis and Cell Cycle Arrest in Neuroblastoma Cells
and Antitumor Effects on Neuroblastoma in Mice. Surgery 2004,
136, 57–66.
(45) Yu, C.; Shin, Y. G.; Kosmeder, J. W.; Pezzuto, J. M.; van Breemen,
R. B. Liquid Chromatography/Tandem Mass Spectrometric De-
termination of Inhibition of Human Cytochrome P450 Isozymes
by Resveratrol and Resveratrol-3-sulfate. Rapid Commun. Mass.
Spectrom. 2003, 17, 307–313.
(46) Farina, A.; Ferranti, C.; Marra, C. An Improved Synthesis of
Resveratrol. Nat. Prod. Res. 2006, 20, 247–252.
(25) Wenzel, E.; Soldo, T.; Erbersdobler, H.; Somoza, V. Bioactivity
and Metabolism of trans-Resveratrol Orally Administered to
Wistar Rats. Mol. Nutr. Food Res. 2005, 49, 482–494.
(47) Raghuraman, A.; Riaz, M.; Hindle, M.; Desai, U. R. Rapid and
Efficient Microwave-Assisted Synthesis of Highly Sulfated Organic
Scaffolds. Tetrahedron Lett. 2007, 48, 6754–6758.
(26) De Santi, C.; Pietrabissa, A.; Spisni, R.; Mosca, F.; Pacifici, G. M.
Sulphation of Resveratrol, a Natural Product Present in Grapes
and Wine, in the Human Liver. Xenobiotica 2000, 30, 609–617.
(27) De Santi, C.; Pietrabissa, A.; Spisni, R.; Mosca, F.; Pacifici, G. M.
Sulfation of Resveratrol, a Natural Compound Present in Wine,
and Its Inhibition by Natural Flavonoids. Xenobiotica 2000, 30,
857–866.
(28) De Santi, C.; Pietrabissa, A.; Mosca, F.; Pacifici, G. M. Glucuro-
nidation of Resveratrol, a Natural Product Present in Grape and
Wine, in the Human Liver. Xenobiotica 2000, 30, 1047–1054.
(29) Kuhnle, G.; Spencer, J. P. E.;; Chowrimootoo, G.; Schroeter, H.;
Debnam, E. S.; Srai, S. K. S.; Rice-Evans, C.; Hahn, U. Resveratrol
Is Absorbed in the Small Intestine as Resveratrol Glucuronide.
Biochem. Biophys. Res. Commun. 2000, 272, 212–217.
(48) Pezzuto, J. M. Resveratrol as an Inhibitor of Carcinogenesis.
Pharm. Biol. 2008, 46, 443–573.
(49) Homhual, S.; Bunyapraphatsara, N.; Kondratyuk, T.; Herunsalee,
A.; Chaukul, W.; Pezzuto, J. M.; Fong, H. H. S.; Zhang, H. J.
Bioactive Dammarane Triterpenes from the Mangrove Plant Bru-
guiera gymnorrhiza. J. Nat. Prod. 2006, 69, 421–424.
(50) Kauffman, F. C.; Whittaker, M.; Anundi, I.; Thurman, R. G.
Futile Cycling of a Sulfate Conjugate by Isolated Hepatocytes.
Mol. Pharmacol. 1991, 39, 414–420.
(51) Nozawa, T.; Suzuki, M.; Yabuuchi, H.; Irokawa, M.; Tsuji, A.;
Tamai, I. Suppression of Cell Proliferation by Inhibition of
Estrone-3-sulfate Transporter in Estrogen-Dependent Breast Cancer
Cells. Pharm. Res. 2005, 22, 1634–1641.
(52) Kwak, J. O.; Kim, H. W.; Oh, K. J.; Ko, C. B.; Park, H.; Cha, S. H.
Characterization of Mouse Rrganic Anion Transporter 5 as a
Renal Steroid Sulfate Transporter. J. Steroid Biochem. Mol. Biol.
2005, 97, 369–375.
(30) Dyke, S. F.; Sainsbury, M.; Brown, D. W.; Palfreyman, M. N.;
Wiggins, D. W. 1,2-Dihydroisoquinolines-XVI Indeno[1,2-c]iso-
quinoline Derivatives. Tetrahedron 1971, 27, 281–289.
(31) Yu, C. W.; Shin, Y. G.; Chow, A.; Li, Y. M.; Kosmeder, J. W.; Lee,
Y. S.; Hirschelman, W. H.; Pezzuto, J. M.; Mehta, R. G.;
van Breemen, R. B. Human, Rat, and Mouse Metabolism of
Resveratrol. Pharm. Res. 2002, 19, 1907–1914.
(32) Vitrac, X.; Desmouliere, A.; Brouillaud, B.; Krisa, S.; Deffieux, G.;
Barthe, N.; Rosenbaum, J.; Merillon, J. M. Distribution of [C-14]-
trans-Resveratrol, a Cancer Chemopreventive Polyphenol, in
Mouse Tissues After Oral Administration. Life Sci. 2003, 72,
2219–2233.
(33) Meng, X. F.; Maliakal, P.; Lu, H.; Lee, M. J.; Yang, C. S. Urinary
and Plasma Levels of Resveratrol and Quercetin in Humans, Mice,
and Rats After Ingestion of Pure Compounds and Grape Juice.
J. Agric. Food Chem. 2004, 52, 935–942.
(34) Walle, T.; Hsieh, F.; DeLegge, M. H.; Oatis, J. E.; Walle, U. K.
High Absorption but Very Low Bioavailability of Oral Resveratrol
in Humans. Drug Metab. Dispos. 2004, 32, 1377–1382.
(35) Goldberg, D. A.; Yan, J.; Soleas, G. J. Absorption of Three Wine-
Related Polyphenols in Three Different Matrices by Healthy
Subjects. Clin. Biochem. 2003, 36, 79–87.
(36) Marier, J.-F.; Vachon, P.; Gritsas, A.; Zhang, J.; Moreau, J. P.;
Ducharme, M. P. Metabolism and Disposition of Resveratrol in
Rats: Extent of Absorption, Glucuronidation, and Enterohepatic
Recirculation Evidenced by a Linked-Rat Model. J. Pharmacol.
Exp. Ther. 2002, 302, 369–373.
(37) Li, Z. G.; Hong, T.; Shimada, Y.; Komoto, I.; Kawabe, A.; Ding,
Y.; Kaganoi, J.; Hashimoto, Y.; Imamura, M. Suppression of
N-Nitrosomethylbenzylamine(NMBA)-InducedEsophagealTumo-
rigenesis in F344 Rats by Resveratrol. Carcinogenesis 2002, 23, 1531–
1536.
(38) Banerjee, S.; Bueso-Ramos, C.; Aggarwal, B. B. Suppression of
7,12-Dimethylbenz(a)anthracene-induced Mammary Carcinogen-
esis in Rats by Resveratrol: Role of Nuclear Factor-KappaB,
Cyclooxygenase 2, and Matrix Metalloprotease 9. Cancer Res.
2002, 62, 4945–4954.
(53) Mizuno, N.; Takahashi, T.; Iwase, Y.; Kusuhara, H.; Niwa, T.;
Sugiyama, Y. Human Organic Anion Transporters 1 (hOAT1/
SLC22A6) and 3 (hOAT3/SLC22A8) Transport Edaravone (MCI-
186; 3-Methyl-1-phenyl-2-pyrazolin-5-one) and Its Sulfate Conju-
gate. Drug Metab. Dispos. 2007, 35, 1429–1434.
(54) Pezzuto, J. M.; Kosmeder, J.; Park, E. J.; Lee, S. K.; Cuendet, M.;
Gills, J. J.; Bhat, K.; Grubjesic, S.; Park, H. S.; Mata-Greenwood,
E.; Tan, Y.; Yu, R.; Lantvit, D. D.; Kinghorn, A. D. Characteriza-
tion of Natural Product Chemopreventive Agents; Humana Press,
Inc.: Totowa, NJ, 2005; Vol. 2, pp 3-37.
(55) Waffo-Teguo, P.; Hawthorne, M. E.; Cuendet, M.; Merillon,
J.-M.; Kinghorn, A. D.; Pezzuto, J. M.; Mehta, R. G. Potential
Cancer-Chemopreventive Activities of Wine Stilbenoids and Fla-
vans Extracted from Grape (Vitis vinifera) Cell Cultures. Nutr.
Cancer 2001, 40, 173–179.
(56) Watanabe, K.; Kawamori, T.; Nakatsugi, S.; Wakabayashi, K.
COX-2 and iNOS, Good Targets for Chemoprevention of Colon
Cancer. BioFactors 2000, 12, 129–133.
(57) Subbaramaiah, K.; Zakim, D.; Weksler, B. B.; Dannenberg, A. J.
Inhibition of Cyclooxygenase: A Novel Approach to Cancer Pre-
vention. Proc. Soc. Exp. Biol. Med. 1997, 216, 201–210.
(58) Kubatka, P.; Ahlers, I.; Ahlersova, E.; Adamekova, E.; Luk, P.;
Bojkova, B.; Markova, M. Chemoprevention of Mammary Carci-
nogenesis in Female Rats by Rofecoxib. Cancer Lett. 2003, 202,
131–136.
(59) Nelson, J. E.; Harris, R. E. Inverse Association of Prostate Cancer
and Non-Steroidal Anti-Inflammatory Dugs (NSAIDs): Results of
a Case-Control Study. Oncol. Rep. 2000, 7, 169–170.
(60) Nakatsugi, S.; Ohta, T.; Kawamori, T.; Mutoh, M.; Tanigawa, T.;
Watanabe, K.; Sugie, S.; Sugimura, T.; Wakabayashi, K. Chemo-
prevention by Nimesulide, a Selective Cyclooxygenase-2 Inhibitor,
of 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)-In-
duced Mammary Gland Carcinogenesis in Rats. Jpn. J. Cancer
Res. 2000, 91, 886–892.
(39) Tessitore, L.; Davit, A.; Sarotto, I.; Caderni, G. Resveratrol
Depresses the Growth of Colorectal Aberrant Crypt Foci by
Affecting bax and p21(CIP) Expression. Carcinogenesis 2000, 21,
1619–1622.
(40) Terao, J. Dietary Flavonoids as Antioxidants in Vivo: Conjugated
Metabolites of (-)-Epicatechin, and Quercetin Participate in Anti-
oxidativeDefenseonBloodPlasma.J. Med. Invest. 1999, 46, 159–168.
(41) Moon, J.; Tsushida, T.; Nakahara, K.; Terao, J. Identification of
Quercetin 3-O-beta-D-Glucoronide as an Antioxidative Metabolite
in Rat Plasma after Oral Administration of Quercetin. Free Radical
Biol. Med. 2001, 30, 1274–1285.
(61) Kleinert, H.; Pautz, A.; Linker, K.; Schwarz, P. M. Regulation of
the Expression of Inducible Nitric Oxide Synthase. Eur. J. Phar-
macol. 2004, 500, 255–266.
(62) Jasnis, M. A.; Giri, J.; Davel, L. Nitric Oxide Is Involved in
Stimulation of Tumor Growth. Oncol. Rep. 1997, 4, 1107–1111.
(63) Wadsworth, T. L.; Koop, D. R. Effects of the Wine Polyphenolics
Quercetin and Resveratrol on Pro-Inflammatory Cytokine Expres-
sion in RAW 264.7 Macrophages. Biochem. Pharmacol. 1999, 57,
941–949.
(64) Tsai, S. H.; Lin-Shiau, S. Y.; Lin, J. K. Suppression of Nitric Oxide
Synthase and the Down-Regulation of the Activation of NF